Background
==========

Successful reproduction is one of the greatest desires of couples in developing countries. Available evidence indicates that infertility is a major problem associated with reproductive health in sub-Saharan Africa.[@b1-tcrm-10-763] The exact prevalence of infertility in developing countries is unknown, due to poor documentation and lack of well-designed studies.[@b2-tcrm-10-763] However, a study in sub-Saharan Africa showed that infertility is highly prevalent, affecting about 10%--30% of couples.[@b3-tcrm-10-763] Several reports indicate that infertility is the most frequent reason for gynecological consultation in Nigeria.[@b4-tcrm-10-763],[@b5-tcrm-10-763] Worldwide, an estimated 580 million couples (approximately 5%--8% of couples) experience infertility at some point in their reproductive lives.[@b6-tcrm-10-763] The consequences of infertility in sub-Saharan Africa are enormous and include marital problems, divorce, depression, stigmatization, isolation, economic hardship, and physical violence, among others.[@b7-tcrm-10-763]--[@b9-tcrm-10-763] Despite this large burden, very few infertility-management programs exist.[@b5-tcrm-10-763] Only very few resources presently exist for the treatment of infertile couples. The conventional methods of infertility treatment are poorly developed in many African countries and little is known about pregnancy outcome after those treatments or about pregnancies which occur spontaneously. In Ghana, a cumulative spontaneous pregnancy rate of 12% was reported among 1,000 infertile patients followed-up for 18 months.[@b10-tcrm-10-763] Infertility treatment by assisted reproductive technology (ART) is expensive and the availability of such services is limited even in developed countries.[@b11-tcrm-10-763]--[@b14-tcrm-10-763] In southeast Nigeria, no public health facility currently offers ART services for infertility. Thus, all infertile couples seeking treatment have limited treatment options, many of which are outdated with poor therapeutic outcome and high rate of loss to follow-up. The paucity of reliable data on the clinical management and therapeutic outcome of infertility in southeast Nigeria necessitate this study to address this problem.

Materials and methods
=====================

This was a prospective cross-sectional study of 218 consecutive infertile couples who presented to the infertility clinics of the University of Nigeria Teaching Hospital and Enugu State University Teaching Hospital, Enugu State, southeast Nigeria between June 1, 2012 and May 31, 2013. The two facilities provide specialized gynecological services to women in the state and also receive referrals from the other neighboring southeast Nigerian states. Ethical clearance was obtained from the Research and Ethical committee of the hospitals. Written signed consent was obtained from the participants. All the female participants received a clinical gynecological examination and all the men received genital examinations by the investigator in conjunction with the urologist. The female participants were investigated accordingly with the available facilities in the University of Nigeria Teaching Hospital and Enugu State University Teaching Hospital. The specific investigations included transabdominal or transvaginal ultrasonography as applicable, hormonal assay, and hysterosalpingography (HSG). All the male partners were referred for semen analysis after 3--5 days of abstinence and results were interpreted according to the new World Health Organization reference value.[@b15-tcrm-10-763] Following investigations, treatment was offered based on the results of investigation/diagnosis. Thereafter, each participant (woman) was followed-up for 6 months for therapeutic outcome (pregnancy). Data were collected using a prepared structured case record form (data entry pro forma). The data entry pro forma contained the sociodemographic characteristics of the patients, duration of infertility, type of infertility, investigation done/results, duration since completion of investigations, treatment offered, and outcome in terms of pregnancy. Data collected from the study were keyed into the Statistical Package for Social Sciences (SPSS Inc., Chicago, IL, USA) computer software version 17.0 for windows. Statistical analysis was both descriptive and inferential (odds ratio \[OR\]) at 95% confidence level (CI). Continuous variables were analyzed using the mean and standard deviation. Discrete variables were analyzed using proportions, Pearson's chi-squared, and multivariate logistic regression as applicable. *P*-value of \<0.05 was considered to be statistically significant.

Results
=======

A total of 1,983 new patients attended the gynecology clinics of the study facilities during the study period, out of which 240 were diagnosed with infertility, giving a prevalence rate of 12.1%. Of the total of 240 infertile couples enrolled in the study, only 218 completed their investigations, giving a completion rate of 90.8%. The mean age of the women was 33.5±4.62 (range: 15--49) years and a majority of the women (63.3% \[n=138\]) were in the 30--39 years age group. Also in the majority were those who were nulliparous (58.3% \[n=127\]) and those who had tertiary level of education (41.3% \[90/218\]). Details of the sociodemographic characteristics of the women are as shown in [Table 1](#t1-tcrm-10-763){ref-type="table"}.

One hundred and fifty-six (71.6%) couples had secondary infertility and 62 (28.4%) had primary infertility. The duration of infertility was less than 5 years in 137 (62.8%) couples, and was 5 years or more in 81 (32.7%) couples.

[Table 2](#t2-tcrm-10-763){ref-type="table"} shows the results of investigations in the women and their male partners. HSG was performed in 211 women. The commonest finding on HSG was tubal blockage (24.6% \[52/211\]); specifically, 2.8% (6/211) had bilateral tubal blockage, 15.6% (34/211) had unilateral blockage, 1.8% (4/211) had unilateral hydrosalpinx, and 3.8% (8/211) had bilateral hydrosalpinx. Uterine synechia was diagnosed in 7.8% (17/211) of the participants.

Pelvic ultrasound (abdominal or transvaginal) was performed on all 218 women. The result was normal in 167 women (76.6%). The commonest abnormalities found on ultrasound were uterine fibroid (15.6%) and polycystic ovaries (10.1%). Hormonal assay findings showed that 26.1% of women had anovulatory infertility. Specifically, hyperprolactinemia was seen in 13.8% of patients and premature ovarian failure in 2.3%. Seminal fluid analysis (SFA) was performed on all 218 men. The result showed normal parameters in 51.8%. Twenty-one (9.6%) had oligozoospermia, three (1.4%) had azoospermia, 18 (8.3%) had asthenozoospermia, seven (3.2%) had teratozoospermia, nine (4.1%) had oligoasthenozoospermia, five (2.3%) had oligoteratozoospermia, four (1.8%) had asthenoteratozoospermia, and 31 (14.2%) showed evidence of infection ([Table 2](#t2-tcrm-10-763){ref-type="table"}). Overall, infertility was found to be due to female factors in 32.1% of couples, male factors in 26.1% of couples, and a combination of male and female factors in 29.4% of couples. The cause of infertility could not be determined in 12.4% of couples.

[Table 3](#t3-tcrm-10-763){ref-type="table"} shows the treatment options offered to the couples; these included ovulation induction with clomiphene citrate, bromocriptine, antibiotics, and surgeries including adhesiolysis, myomectomy, and salpingostomy. Fourteen women with severe tubal-factor infertility (bilateral tubal blockage or hydrosalpinx), five women with premature ovarian failure, and 28 women whose husbands had severe abnormal SFA result were counseled on adoption or ART. None of these women referred for ART underwent the procedure because of the prohibitive cost. Also, none of these women undertook the option of adoption. Fifteen men were referred to the urologist for further evaluation of their abnormal SFA result shown in [Table 2](#t2-tcrm-10-763){ref-type="table"}, while [Table 4](#t4-tcrm-10-763){ref-type="table"} shows the treatment received.

Of the 218 women and 168 (77.1%) male partners who were followed-up to 6 months (50 \[22.9%\] male partners defaulted), 28 (16.6%) women reported pregnancy symptoms and these were confirmed with a positive pregnancy test and ultrasound scan. Younger women aged ≤30 years were significantly more likely to achieve pregnancy following conventional infertility treatment than older women aged \>30 years (23.2% \[13/56\] versus 9.3% \[15/162\]; OR =2.96; 95% CI =1.31--6.71; *P*=0.01). Similarly, couples whose duration of infertility was ≤5 years were significantly more likely to achieve pregnancy following conventional infertility treatment than couples whose duration of infertility was \>5 years (16.8% \[23/137\] versus 6.2% \[5/81\]; OR =3.07; 95% CI =1.12--8.42; *P*=0.03). Furthermore, couples with female-factor infertility were significantly more likely to achieve pregnancy following conventional infertility treatment than couples with male-factor or combined male- and female-factors infertility (22.9% \[16/70\] versus 9.9% \[12/121\]; OR =2.69; 95% CI =1.19--6.09; *P*=0.02). Couples with primary infertility were more likely to achieve pregnancy following conventional infertility treatment than couples with secondary infertility; however, the observed difference was not statistically significant (14.5% \[9/62\] versus 12.2% \[19/156\]; OR =1.22; 95% CI =0.52--2.88; *P*=0.64). Further details are shown in [Table 5](#t5-tcrm-10-763){ref-type="table"}.

Discussion
==========

The prevalence of infertility (12.1%) in the study population is high but comparable to reports from some related studies from southeast Nigeria.[@b16-tcrm-10-763],[@b17-tcrm-10-763] The figure is however higher than the 5.5% prevalence obtained in a previous retrospective study from the same study area.[@b18-tcrm-10-763] The higher incidence may be explained by the improved health-seeking behavior of the populace in addition to increasing awareness that infertility is a gynecological condition that is treatable and not "a punishment by the ancestral gods" as previously held. Further studies however may be necessary to confirm these assumptions. The peak age incidence of infertility in this study was in women aged 30--39 years (63.3%) and men also aged 30--39 years (69.7%). Higher rates of infertility in older women is attributable primarily to decline in fertility rate with advancing age.[@b4-tcrm-10-763] This finding is similar to the incidence reported in a previous study from the present study area[@b18-tcrm-10-763] and among infertile couples in a southwest Nigerian community,[@b12-tcrm-10-763] but is at variance with the report from Calabar, Nigeria.[@b19-tcrm-10-763] The majority of the women in this present study were civil servants (career women) who might have postponed marriage and child birth in pursuit of their career.

The predominance of secondary infertility (71.6%) in this study is similar to findings obtained in previous studies in our environment;[@b18-tcrm-10-763]--[@b20-tcrm-10-763] this is however contrary to reports from developed countries where primary infertility is more prevalent, accounting for 61%--71% of cases, and secondary infertility is responsible for 29%--33% of cases.[@b21-tcrm-10-763] This high rate of secondary female infertility obtained in this study suggests that the outcome of the last pregnancy may play an important role in the etiology of infertility. The sequela of tubal damage caused by pelvic infection resulting from ascending infection during childbirth has been amply documented by other workers.[@b22-tcrm-10-763]--[@b24-tcrm-10-763] Infections and their sequela no doubt played an important role in the etiology of infertility in both males and females. In this study, they accounted for about 14.2% of all causes of infertility in men. Oligospermia, teratozoospermia, azoospermia, asthenozoospermia, and a combination of oligoasthenozoospermia, oligoteratozoospermia, and asthenoteratozoospermia were the various semen parameter abnormalities observed in the study. The rate of asthenozoospermia (17.4%) as observed in the male partners in this study is similar to reports from previous studies.[@b25-tcrm-10-763],[@b26-tcrm-10-763]

This study showed a greater contribution of female factor (32.1%) in the etiology of infertility as opposed to male factor (26.1%) and this is similar to the findings from previous studies from Nigeria.[@b20-tcrm-10-763]--[@b21-tcrm-10-763] Tubal factor was identified in the majority of cases with identifiable causes and this is no doubt a common cause of infertility seen in many gynecology clinics in Nigeria.[@b12-tcrm-10-763]--[@b13-tcrm-10-763] Early presentation of infertile couples for assessment and treatment was common in this study as 62.8% of patients presented within 5 years of infertility. This could be attributed to the fact that most of the women were well educated; evidenced by 41.2% having tertiary education. It could also be explained by the high premium placed on childbirth among the Igbo in Nigeria.[@b18-tcrm-10-763] The low pregnancy rate of 16.7% obtained in the present study is similar to the 17.0% obtained in a previous retrospective design from the same study area. This figure is however lower than the 22.4% reported by Giwa-Osagie et al from Lagos[@b14-tcrm-10-763] and the 24.0% reported by Ekwere et al from Calabar.[@b19-tcrm-10-763] Nevertheless, the short follow-up period of 6 months in this study may contribute to the lower pregnancy rate compared to the other two older studies as pregnancy may not occur for over 6 months after commencement of some infertility treatments.[@b27-tcrm-10-763] The low pregnancy rate recorded in this study reaffirms the notion that conventional treatment for infertility is not enough and that only few infertile couples can be treated effectively without ART as the majority will need in vitro fertilization and embryo transfer/intracytoplasmic sperm injection.[@b13-tcrm-10-763] The current cost of ART prohibits its wide-spread use in resource-poor countries where the burden of infertility is high. This is evidenced in this study by the fact that none of the couples referred for ART had been able to undertake the procedure because of the exorbitant cost. This study therefore reemphasizes the need for the implementation of ART in low-income countries including Nigeria.

Strength and limitation of the study
====================================

The lack of a functional laparoscope and hysteroscope in the study centers at the time of this study might have limited the scope of diagnosis made among infertile couples. The limited duration of follow-up of the women after commencement of treatment may have affected the pregnancy rate obtained in this report since some other women may achieve pregnancy following longer follow-up. The strength of this study however is in its prospective design with relatively reduced default rates/losses to follow-up which were major limitations of most previous designs on infertility management and outcome in our environment.

Conclusion
==========

The prevalence of infertility is high and secondary infertility is more common. There is a high rate of unexplained infertility. Tubal factors and ovulation failures are commonly implicated in cases with identifiable female factors. The pregnancy rate following conventional treatment was poor. Younger age, shorter duration of infertility, and female-factor infertility were associated with better therapeutic outcome (pregnancy) following conventional infertility treatment. There is need to improve facilities for managing infertility as well as provide updated facilities for fertility-related endoscopic procedures and artificial reproductive techniques at affordable cost.
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###### 

Sociodemographic characteristics of the female and male participants

  Variables            Female, n (%)   Male, n (%)
  -------------------- --------------- -------------
  Age (years)                          
   \<20                2 (0.9)         0 (0)
   20--29              50 (22.9)       8 (3.7)
   30--39              138 (63.3)      152 (69.7)
   40 or more          28 (12.8)       58 (26.6)
  Parity                               
   Nulliparous         127 (58.3)      N/A
   Primiparous         57 (26.1)       N/A
   Multiparous         32 (14.7)       N/A
   Grand multiparous   2 (0.9)         N/A
  Educational level                    
   Primary             34 (15.6)       20 (9.2)
   Secondary           87 (39.9)       143 (65.6)
   Tertiary            90 (41.3)       55 (25.2)

**Abbreviation:** N/A, not applicable.

###### 

Outcome of infertility investigations and diagnosis

  Diagnosis                            n (%)
  ------------------------------------ ------------
  Female                               
  Tubal assessment n=211               
   Normal                              159 (72.9)
   Bilateral tubal blockage            6 (2.8)
   Unilateral tubal blockage           34 (15.6)
   Unilateral hydrosalpinx             4 (1.8)
   Bilateral hydrosalpinx              8 (3.7)
  Uterine assessment n=218             
   Normal                              167 (76.6)
   Fibroid                             34 (15.6)
   Uterine synechia                    17 (7.8)
  Ovulation failure assessment n=218   
   Normal                              161 (73.9)
   Hyperprolactinaemia                 30 (13.8)
   Premature ovarian failure           5 (2.3)
   PCOS                                22 (10.1)
  Male n=218                           
   Normal                              113 (51.8)
   Oligozoospermia                     21 (9.6)
   Azoospermia                         3 (1.4)
   Asthenozoospermia                   18 (8.3)
   Teratozoospermia                    7 (3.2)
   Oligoasthenozoospermia              9 (4.1)
   Oligoteratozoospermia               5 (2.3)
   Asthenoteratozoospermia             7 (3.2)
   Oligoasthenoteratozoospermia        4 (1.8)
   Genital (seminal) infection         31 (14.2)

**Abbreviation:** PCOS, polycystic ovarian syndrome.

###### 

Treatment options offered to the women after infertility investigation/diagnosis

  Treatment (n=168)                                           n (%)
  ----------------------------------------------------------- -----------
  No treatment (counseling/reassurance)                       19 (11.3)
  Referred for adoption/IVF                                   47 (27.9)
  Ovulation induction with CC only                            15 (8.9)
  Ovulation induction with bromocriptine only                 21 (12.5)
  Ovulation induction with CC and metformin                   2 (1.2)
  Ovulation induction with CC and bromocriptine               2 (1.2)
  Ovulation induction with CC, metformin, and bromocriptine   1 (0.6)
  Antibiotics for genital infections                          12 (7.1)
  Myomectomy                                                  19 (11.3)
  Tubal surgery (salpingostomy)                               2 (1.2)
  Adhesiolysis                                                13 (7.7)
  Referred (husbands) to urologists                           15 (8.9)

**Abbreviations:** CC, clomiphene citrate; IVF, in vitro fertilization.

###### 

Treatment options offered to male partners (n=168) of women managed for infertility

  Treatment[\*](#tfn4-tcrm-10-763){ref-type="table-fn"}   n (%)
  ------------------------------------------------------- -----------
  No treatment (counseling/reassurance)                   26 (15.1)
  Antibiotics for genital infections                      94 (54.7)
  Hormonal therapy                                        15 (8.7)
  Referred for assisted conception (IVF)                  37 (21.5)

**Note:**

More than one treatment may have been offered.

**Abbreviation:** IVF, in vitro fertilization.

###### 

Determinants of pregnancy following conventional treatment among the infertile couples

  Variables                  Pregnancy   OR           *P*-value   95% CI                                              
  -------------------------- ----------- ------------ ----------- --------------------------------------------------- --------------
  Age of the woman (years)                                                                                            
   ≤30                       13 (23.2)   43 (76.8)    2.963       0.009[\*](#tfn6-tcrm-10-763){ref-type="table-fn"}   1.309--6.705
   \>30                      15 (9.3)    147 (90.7)                                                                   
  Infertility type                                                                                                    
   Primary                   9 (14.5)    53 (85.5)    1.224       0.643                                               0.521--2.877
   Secondary                 19 (12.2)   137 (87.8)                                                                   
  Infertility duration                                                                                                
   \<5 years                 23 (16.8)   114 (83.2)   3.067       0.030[\*](#tfn6-tcrm-10-763){ref-type="table-fn"}   1.117--8.418
   5 years and above         5 (6.2)     76 (93.8)                                                                    
  Who is responsible                                                                                                  
   Female                    16 (22.9)   54 (77.1)    2.691       0.018[\*](#tfn6-tcrm-10-763){ref-type="table-fn"}   1.190--6.090
   Male or both              12 (9.9)    109 (90.1)                                                                   

**Note:**

Statistically significant.

**Abbreviations:** CI, confidence interval; OR, odds ratio.
